Neurotech International
(ASX:NTI)
Cannabis
| Our Entry Price $ | Current Price $ | Current Return | Highest Price $ | Highest Return |
|---|---|---|---|---|
| $ 0.062 | $ 0.071 | 15% | $ 0.078 | 26% |
Market Data
Latest Article
Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism
Jul 10, 2018
Leading medical device company Neurotech International (ASX:NTI) this week reported highly promising results from US clinical trials of its Mente autism device.
Related Articles
Revolutionary MedTech Device: a New Frontier in Autism Treatment
Jun 26, 2018
Today’s company has created the first and only regulated medical device for the management of autism in a home setting.
